IN8BIO, INC. Earnings Per Share (Basic)
IN8BIO, INC. (INAB) reported Earnings Per Share (Basic) of -$0.25 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- IN8BIO, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.25.
- IN8BIO, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.26.
- IN8BIO, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.85.
- IN8BIO, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$1.24.
- IN8BIO, INC. earnings per share, basic for fiscal 2025 was -$4.44.
- IN8BIO, INC. earnings per share, basic for fiscal 2024 was -$17.05.
- IN8BIO, INC. earnings per share, basic for fiscal 2023 was -$1.00.
- IN8BIO, INC. earnings per share, basic for fiscal 2022 was -$1.36.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.25 10-Q · filed 2026-08-06 | -$0.51 10-Q · filed 2026-08-06 | ||||||
| 2026-03-31 | -$0.26 10-Q · filed 2026-05-07 | |||||||
| 2025-12-31 | -$4.44 10-K · filed 2026-03-12 | |||||||
| 2025-09-30 | -$0.85 10-Q · filed 2025-11-06 | -$4.18 10-Q · filed 2025-11-06 | ||||||
| 2025-06-30 | -$1.24 10-Q · filed 2026-08-06 | -$3.65 10-Q · filed 2026-08-06 | ||||||
| 2025-03-31 | -$2.16 10-Q · filed 2026-05-07 | -$0.07 10-Q · filed 2025-05-07 | ||||||
| 2024-12-31 | -$17.05 10-K · filed 2026-03-12 | -$0.57 10-K · filed 2025-03-13 | ||||||
| 2024-09-30 | -$4.49 10-Q · filed 2025-11-06 | -$0.15 10-Q · filed 2024-11-12 | -$16.02 10-Q · filed 2025-11-06 | -$0.53 10-Q · filed 2024-11-12 | ||||
| 2024-06-30 | -$5.51 10-Q · filed 2025-08-07 | -$0.19 10-Q · filed 2024-08-08 | -$11.59 10-Q · filed 2025-08-07 | -$0.39 10-Q · filed 2024-08-08 | ||||
| 2024-03-31 | -$0.20 10-Q · filed 2025-05-07 | |||||||
| 2023-12-31 | -$1.00 10-K · filed 2025-03-13 | |||||||
| 2023-09-30 | -$0.23 10-Q · filed 2024-11-12 | -$0.79 10-Q · filed 2024-11-12 | ||||||
| 2023-06-30 | -$0.27 10-Q · filed 2024-08-08 | -$0.57 10-Q · filed 2024-08-08 | ||||||
| 2023-03-31 | -$0.30 10-Q · filed 2024-05-09 | |||||||
| 2022-12-31 | -$1.36 10-K · filed 2024-03-14 | |||||||
| 2022-09-30 | -$0.34 10-Q · filed 2023-11-09 | -$0.72 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$1.05 10-Q · filed 2023-11-09 | -$1.36 derived: net income ÷ weighted average shares · filed 2023-11-09 | ||||
| 2022-06-30 | -$0.38 10-Q · filed 2023-08-10 | -$0.71 10-Q · filed 2023-08-10 | -$1.02 derived: net income ÷ weighted average shares · filed 2023-08-10 | -$1.29 derived: net income ÷ weighted average shares · filed 2023-08-10 | ||||
| 2022-03-31 | -$0.33 10-Q · filed 2023-05-12 | -$0.64 derived: net income ÷ weighted average shares · filed 2023-05-12 | -$0.90 derived: net income ÷ weighted average shares · filed 2023-05-12 | -$1.40 derived: net income ÷ weighted average shares · filed 2023-05-12 | ||||
| 2021-12-31 | -$0.31 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$0.57 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$1.08 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$1.47 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | -$0.25 10-Q · filed 2022-11-10 | -$0.83 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$1.26 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | -$1.00 10-Q · filed 2022-08-12 | -$1.82 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B |